Navigation Links
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
Date:11/1/2012

LYNBROOK, N.Y., Nov. 1, 2012 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, announced today that it will host a conference call and live audio webcast at 4:30 p.m. EST on Thursday, November 8, 2012 to report its third quarter 2012 financial results and provide a corporate update.

In order to participate in the conference call, please dial 1-800-860-2442 (domestic) or 1-412-858-4600 (international). The live webcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com or you may use the link: http://www.videonewswire.com/event.asp?id=90670.

A replay of the call will be available one hour after the end of the conference on November 8, 2012 until 9:00 a.m. EST on November 23, 2012. To access the replay, please dial 1-877-344-7529 (domestic) or 1-412-317-0088 (international) and reference the access code 10020975. The archived webcast will be available for 90 days in the Investor Relations section of BioSpecifics' website at www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Currently, injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is also in clinical development for the treatment of several additional promising indications. Auxilium has reported positive top-line results from two recently completed Phase III clinical trials for Peyronie's disease and is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials.  Auxilium has entered into three strategic partnerships for development and commercialization outside the U.S. of injectable collagenase for Dupuytren's contracture and Peyronie's disease. Pfizer Inc. has rights in Europe and Eurasia and injectable collagenase is currently marketed as XIAPEX® for Dupuytren's contracture in select European countries. Asahi Kasei Pharma Corporation has rights in Japan and Actelion Pharmaceuticals Ltd. has rights in Canada, Australia, Brazil and Mexico. For more information, please visit www.biospecifics.com.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
5. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
6. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
7. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
8. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
9. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
10. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
11. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2019)... ... December 09, 2019 , ... American ... throughout North America has released its documentary on " Making Data Work: Leveraging ... how pharmaceutical companies are currently using data to produce products, and how they ...
(Date:12/8/2019)... ... December 07, 2019 , ... Intelligent.com ... potential with career opportunities upon graduation from these top ranked institutions. , Intelligent.com, ... the Top 44 Nutrition Degree Programs for 2020. The comprehensive research guide is ...
(Date:12/8/2019)... ... ... A new study from researchers at the UConn Rudd Center for Food Policy ... food, unhealthy snacks, candy and soft drinks filled with sugar. , Overindulging ... family members visiting from out of town. But a new report says social ...
Breaking Medicine Technology:
(Date:12/14/2019)... ... ... For two years, the only hospital in the Middle Florida Keys has ... would make you think of the temporary buildings you would see at school growing ... building and the hospital carried on, first in tents and then in these buildings. ...
(Date:12/9/2019)... ... 09, 2019 , ... Greenlight Guru, quality management system ... - - Change Management capabilities . The enhanced Change Management capabilities include ... impacted by change orders in a collaborative change workspace, while also ensuring connectivity ...
(Date:12/8/2019)... ... December 07, 2019 , ... More than 85 million ... recent report from the American Academy of Dermatology, indicating this problem is more common ... trend during the years to come. These dermatological conditions vary in type and severity ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... recruiting, has been recognized for excellence in employee learning. The Omaha-based company has ... ranks organizations with the most successful employer-sponsored training and development programs worldwide. Rankings ...
(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named Kymberly ... AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair of ... chair since October and is also part of the pathology faculty at Drexel University ...
Breaking Medicine News(10 mins):